274 related articles for article (PubMed ID: 11124980)
1. Potentiated opioid analgesia in norepinephrine transporter knock-out mice.
Bohn LM; Xu F; Gainetdinov RR; Caron MG
J Neurosci; 2000 Dec; 20(24):9040-5. PubMed ID: 11124980
[TBL] [Abstract][Full Text] [Related]
2. Dual allosteric modulation of opioid antinociceptive potency by α2A-adrenoceptors.
Chabot-Doré AJ; Millecamps M; Naso L; Devost D; Trieu P; Piltonen M; Diatchenko L; Fairbanks CA; Wilcox GL; Hébert TE; Stone LS
Neuropharmacology; 2015 Dec; 99():285-300. PubMed ID: 26254859
[TBL] [Abstract][Full Text] [Related]
3. Tramadol antinociception is potentiated by clonidine through α₂-adrenergic and I₂-imidazoline but not by endothelin ET(A) receptors in mice.
Andurkar SV; Gendler L; Gulati A
Eur J Pharmacol; 2012 May; 683(1-3):109-15. PubMed ID: 22449379
[TBL] [Abstract][Full Text] [Related]
4. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
5. alpha(2C)-Adrenergic receptors mediate spinal analgesia and adrenergic-opioid synergy.
Fairbanks CA; Stone LS; Kitto KF; Nguyen HO; Posthumus IJ; Wilcox GL
J Pharmacol Exp Ther; 2002 Jan; 300(1):282-90. PubMed ID: 11752127
[TBL] [Abstract][Full Text] [Related]
6. Differential mechanisms mediating descending pain controls for antinociception induced by supraspinally administered endomorphin-1 and endomorphin-2 in the mouse.
Ohsawa M; Mizoguchi H; Narita M; Chu M; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2000 Sep; 294(3):1106-11. PubMed ID: 10945866
[TBL] [Abstract][Full Text] [Related]
7. Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice.
Bohn LM; Lefkowitz RJ; Caron MG
J Neurosci; 2002 Dec; 22(23):10494-500. PubMed ID: 12451149
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors.
Gergen KA; Zadina JE; Kastin AJ; Paul D
Eur J Pharmacol; 1996 Mar; 298(3):235-9. PubMed ID: 8846821
[TBL] [Abstract][Full Text] [Related]
9. Involvement of I2-imidazoline binding sites in positive and negative morphine analgesia modulatory effects.
Gentili F; Cardinaletti C; Carrieri A; Ghelfi F; Mattioli L; Perfumi M; Vesprini C; Pigini M
Eur J Pharmacol; 2006 Dec; 553(1-3):73-81. PubMed ID: 17081513
[TBL] [Abstract][Full Text] [Related]
10. A role for spinal, but not supraspinal, alpha(2) adrenergic receptors in the actions of improgan, a powerful, non-opioid analgesic.
Svokos K; Nalwalk JW; Leurs R; Menge WM; Timmerman H; Hough LB
Brain Res; 2001 Dec; 923(1-2):12-9. PubMed ID: 11743967
[TBL] [Abstract][Full Text] [Related]
11. The alpha2a adrenergic receptor subtype mediates spinal analgesia evoked by alpha2 agonists and is necessary for spinal adrenergic-opioid synergy.
Stone LS; MacMillan LB; Kitto KF; Limbird LE; Wilcox GL
J Neurosci; 1997 Sep; 17(18):7157-65. PubMed ID: 9278550
[TBL] [Abstract][Full Text] [Related]
12. Spinal and supraspinal agmatine activate different receptors to enhance spinal morphine antinociception.
Roerig SC
Ann N Y Acad Sci; 2003 Dec; 1009():116-26. PubMed ID: 15028575
[TBL] [Abstract][Full Text] [Related]
13. Supraspinal and spinal delta(2) opioid receptor-mediated antinociceptive synergy is mediated by spinal alpha(2) adrenoceptors.
Grabow TS; Hurley RW; Banfor PN; Hammond DL
Pain; 1999 Oct; 83(1):47-55. PubMed ID: 10506671
[TBL] [Abstract][Full Text] [Related]
14. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
Kögel B; Christoph T; Strassburger W; Friderichs E
Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
[TBL] [Abstract][Full Text] [Related]
15. The delta-opioid receptor is sufficient, but not necessary, for spinal opioid-adrenergic analgesic synergy.
Chabot-Doré AJ; Millecamps M; Stone LS
J Pharmacol Exp Ther; 2013 Dec; 347(3):773-80. PubMed ID: 24039246
[TBL] [Abstract][Full Text] [Related]
16. Differential modulation of alpha 2-adrenergic and mu-opioid spinal antinociception by neuropeptide FF.
Kontinen VK; Kalso EA
Peptides; 1995; 16(5):973-7. PubMed ID: 7479344
[TBL] [Abstract][Full Text] [Related]
17. Contribution of GIRK2-mediated postsynaptic signaling to opiate and alpha 2-adrenergic analgesia and analgesic sex differences.
Mitrovic I; Margeta-Mitrovic M; Bader S; Stoffel M; Jan LY; Basbaum AI
Proc Natl Acad Sci U S A; 2003 Jan; 100(1):271-6. PubMed ID: 12496346
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the analgesic effect of centhaquin in mouse tail flick and hot-plate tests.
Andurkar SV; Gulati A
Pharmacology; 2011; 88(5-6):233-41. PubMed ID: 21997570
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal atipamezole augments the antinociceptive effect of morphine in rats.
Lilius TO; Rauhala PV; Kambur O; Rossi SM; Väänänen AJ; Kalso EA
Anesth Analg; 2012 Jun; 114(6):1353-8. PubMed ID: 22556211
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of the analgesic properties of fentanyl-like opioids with alpha 2-adrenoceptor agonists in rats.
Meert TF; De Kock M
Anesthesiology; 1994 Sep; 81(3):677-88. PubMed ID: 7916547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
